Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory Drops After Laser Peripheral Iridotomy
NCT02955641Unknown
- Sponsor
- Sheba Medical Center
- Start
- Nov 2016
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of nepafenac and dexamethasone in primary angle-closure glaucoma (PACG) (4 arms), sponsored by Sheba Medical Center. Primary endpoints: Pain score at 4 days and Symptoms score at 4 days. Status: unknown.
02
Drugs
nepafenacdexamethasone
03
Conditions
primary angle-closure glaucoma (PACG)
Beyond the preview
Go deeper on NCT02955641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955641.